Pfizer Inc <a href="https://www.reuters.com/companies/PFE.N" target="_blank">(PFE.N)</a> on Tuesday raised its forecast for annual sales of its COVID-19 vaccine by $2 billion to $34 billion on demand for Omicron-targeted boosters, helping allay some investor …